2 stage PK study in 3 prototype buprenorphine patches
Research type
Research Study
Full title
A stage 2, randomised, open-label, crossover design pharmacokinetic study of relative and absolute bioavailability and dose proportionality in 3 prototype Buprenorphine Transdermal Deliver System second generation patches.
IRAS ID
82833
Contact name
David J A Bell
Contact email
Sponsor organisation
Mundipharma Research Ltd
Eudract number
2011-000974-69
Research summary
Research Summary not published at request of researcher
REC name
HSC REC A
REC reference
11/NI/0103
Date of REC Opinion
8 Aug 2011
REC opinion
Further Information Favourable Opinion